Found 5 matching trials
A Study to Evaluate Safety and Efficacy of WSD0922-FU Combo With Osimertinib for NSCLC
PHASE1This is a Phase I/II, Open Label Study of WSD0922-FU in Combination with Os...
Location
Shanghai East Hospital
A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
PHASE2This is a Phase II, Open Label, Multicenter, Single Arm Study of WSD0922-FU...
Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma
PHASE2This phase II trial compares the effect of adding WSD0922-FU to temozolomid...
Location
Mayo Clinic in Arizona
WSD0922-FU for Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases
PHASE1This phase I trial studies the side effects and best dose of WSD0922-FU for...
Status
Active Not Recruiting
Location
Mayo Clinic in Arizona
A Study to Assess the Efficacy and Safety of WSD0922-FU in Patients With EGFRm+ Advanced Non-small Cell Lung Cancer
PHASE1This study is a multicenter, open label, single-arm phase I/II clinical tri...
Location
Anhui Provincial Hospital